MENU
MRKR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Marker Therapeutics (MRKR) Ownership - Who owns Marker Therapeutics?

Profile

Industry
Other Consumer Services
Address
9350 Kirby Drive
Phone
+1 713 400-6400
Employees
8
Web
http//www.markertherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
43.37M
P/E Ratio
N/A
Total Cash
9M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
1.78
Dividend Yield
N/A
Total Cash/Share
1.01
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

MRKR
Capitalization
43.4M
P/E Ratio
N/A
Risk (Beta)
1.78
Dividend Yield
N/A
Total Cash
9M
Total Cash/Share
1.01
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
7.45M
P/B Ratio
5.82
Cash Flow
N/A
Earnings
-1.09
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
8.92K
Current Ratio
3.15
Current Revenue Per Employee
52238.81
Dividends Per Share - Security
N/A
EBITDA
-10.19M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.01
Revenue To Assets
-63.80
Shares Held By Institutions
9.69M
Shares Outstanding - Current
8.92M
Total Liabilities
3.46M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-11.636
View a ticker or compare two or three
MRKR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of cell based immune therapeutics and vaccines for cancer treatment

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Other Consumer Services
Address
9350 Kirby Drive
Phone
+1 713 400-6400
Employees
8
Web
http//www.markertherapeutics.com